Chapman JD - Search Results

1

Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings.

Movsas B, Chapman JD, Hanlon AL, Horwitz EM, Greenberg RE, Stobbe C, Hanks GE, Pollack A. Movsas B, et al. Among authors: chapman jd. Urology. 2002 Oct;60(4):634-9. doi: 10.1016/s0090-4295(02)01858-7. Urology. 2002. PMID: 12385924

2

Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha/beta ratio.

Nahum AE, Movsas B, Horwitz EM, Stobbe CC, Chapman JD. Nahum AE, et al. Among authors: chapman jd. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):391-401. doi: 10.1016/s0360-3016(03)00534-0. Int J Radiat Oncol Biol Phys. 2003. PMID: 12957250

3

Hypoxic regions exist in human prostate carcinoma.

Movsas B, Chapman JD, Horwitz EM, Pinover WH, Greenberg RE, Hanlon AL, Iyer R, Hanks GE. Movsas B, et al. Among authors: chapman jd. Urology. 1999 Jan;53(1):11-8. doi: 10.1016/s0090-4295(98)00500-7. Urology. 1999. PMID: 9886581

4

Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO(2) study.

Movsas B, Chapman JD, Greenberg RE, Hanlon AL, Horwitz EM, Pinover WH, Stobbe C, Hanks GE. Movsas B, et al. Among authors: chapman jd. Cancer. 2000 Nov 1;89(9):2018-24. doi: 10.1002/1097-0142(20001101)89:9<2018::aid-cncr19>3.3.co;2-p. Cancer. 2000. PMID: 11064360

5

Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer.

Cvetkovic D, Movsas B, Dicker AP, Hanlon AL, Greenberg RE, Chapman JD, Hanks GE, Tricoli JV. Cvetkovic D, et al. Among authors: chapman jd. Urology. 2001 Apr;57(4):821-5. doi: 10.1016/s0090-4295(00)01044-x. Urology. 2001. PMID: 11306422

6

Hypoxia in human prostate carcinoma: an Eppendorf PO2 study.

Movsas B, Chapman JD, Hanlon AL, Horwitz EM, Pinover WH, Greenberg RE, Stobbe C, Hanks GE. Movsas B, et al. Among authors: chapman jd. Am J Clin Oncol. 2001 Oct;24(5):458-61. doi: 10.1097/00000421-200110000-00009. Am J Clin Oncol. 2001. PMID: 11586096

7

Radiation inactivation of human prostate cancer cells: the role of apoptosis.

Algan O, Stobbe CC, Helt AM, Hanks GE, Chapman JD. Algan O, et al. Among authors: chapman jd. Radiat Res. 1996 Sep;146(3):267-75. Radiat Res. 1996. PMID: 8752304

8

Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays.

Chapman JD, Engelhardt EL, Stobbe CC, Schneider RF, Hanks GE. Chapman JD, et al. Radiother Oncol. 1998 Mar;46(3):229-37. doi: 10.1016/s0167-8140(97)00186-2. Radiother Oncol. 1998. PMID: 9572615 Review.

9

Single-photon emission computed tomography and positron-emission tomography assays for tissue oxygenation.

Chapman JD, Schneider RF, Urbain JL, Hanks GE. Chapman JD, et al. Semin Radiat Oncol. 2001 Jan;11(1):47-57. doi: 10.1053/srao.2001.18103. Semin Radiat Oncol. 2001. PMID: 11146042 Review.

10

Marking hypoxia in rat prostate carcinomas with beta-D-[125I]azomycin galactopyranoside and.

Iyer RV, Haynes PT, Schneider RF, Movsas B, Chapman JD. Iyer RV, et al. Among authors: chapman jd. J Nucl Med. 2001 Feb;42(2):337-44. J Nucl Med. 2001. PMID: 11216534 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

461 results

Search Page